secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2022-05-11T23:59:59+00:00
Accession:  0001193125-22-147554
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed President of Sleep and Respiratory Care Jim Hollingshead resigns; Rob Douglas named interim
--------------------------------------------------------------------------------

- Jim Hollingshead resigned effective May 5, 2022 to pursue a new opportunity.
- Rob Douglas, ResMed's President and COO, appointed interim president of Sleep and Respiratory Care.
- CEO Mick Farrell acknowledged Hollingshead's 12 years of service and contributions.
- Company will begin a search for a permanent president for the sleep and respiratory care business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312522147554/0001193125-22-147554-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312522147554/d309157d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-147554

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer